Q1. Under the Biopharma SHAKTI scheme, the dedicated 'scientific review cadre' of specialists is to be created within which one of the following, identified as the lead drug regulator to be strengthened to global standards?
- A. Central Drugs Standard Control Organisation (CDSCO)
- B. Indian Council of Medical Research (ICMR)
- C. National Pharmaceutical Pricing Authority (NPPA)
- D. Drugs Technical Advisory Board (DTAB)